These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of the expression of TGF-β1 and CTGF in human mesangial cells by exendin-4, a glucagon-like peptide-1 receptor agonist. Li W; Cui M; Wei Y; Kong X; Tang L; Xu D Cell Physiol Biochem; 2012; 30(3):749-57. PubMed ID: 22890152 [TBL] [Abstract][Full Text] [Related]
7. Activation of GLP-1 and gastrin signalling induces in vivo reprogramming of pancreatic exocrine cells into beta cells in mice. Sasaki S; Miyatsuka T; Matsuoka TA; Takahara M; Yamamoto Y; Yasuda T; Kaneto H; Fujitani Y; German MS; Akiyama H; Watada H; Shimomura I Diabetologia; 2015 Nov; 58(11):2582-91. PubMed ID: 26290048 [TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Wan S; Coleman FH; Travagli RA Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1474-82. PubMed ID: 17322063 [TBL] [Abstract][Full Text] [Related]
9. In vivo treatment with glucagon-like peptide 1 promotes the graft function of fetal islet-like cell clusters in transplanted mice. Suen PM; Li K; Chan JC; Leung PS Int J Biochem Cell Biol; 2006; 38(5-6):951-60. PubMed ID: 16172015 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells. Peyot ML; Gray JP; Lamontagne J; Smith PJ; Holz GG; Madiraju SR; Prentki M; Heart E PLoS One; 2009 Jul; 4(7):e6221. PubMed ID: 19593440 [TBL] [Abstract][Full Text] [Related]
11. beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Li Y; Cao X; Li LX; Brubaker PL; Edlund H; Drucker DJ Diabetes; 2005 Feb; 54(2):482-91. PubMed ID: 15677506 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477 [TBL] [Abstract][Full Text] [Related]
13. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells. Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053 [TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 and islet lipolysis. Sörhede Winzell M; Ahrén B Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711 [TBL] [Abstract][Full Text] [Related]
15. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Xu G; Stoffers DA; Habener JF; Bonner-Weir S Diabetes; 1999 Dec; 48(12):2270-6. PubMed ID: 10580413 [TBL] [Abstract][Full Text] [Related]
16. Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-beta1. Moritani M; Yamasaki S; Kagami M; Suzuki T; Yamaoka T; Sano T; Hata J; Itakura M Mol Cell Endocrinol; 2005 Jan; 229(1-2):175-84. PubMed ID: 15607541 [TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Perfetti R; Zhou J; Doyle ME; Egan JM Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273 [TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect. Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284 [TBL] [Abstract][Full Text] [Related]
19. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346 [TBL] [Abstract][Full Text] [Related]
20. Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors. Zhou J; Pineyro MA; Wang X; Doyle ME; Egan JM J Cell Physiol; 2002 Sep; 192(3):304-14. PubMed ID: 12124776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]